Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:MRK
Merck
|
128.26 | -7.99% | 5.47% | 324,886.2 | 2.39% | -19.03% |
|
SWX:NOVN
Novartis
|
88.87 | 13.62% | 27.66% | 181,330.92 | 3.71% | 4.67% |
|
NYSE:ZTS
Zoetis
|
167.23 | 32.3% | 48.67% | 76,415.28 | 1.09% | 11.19% |
|
NYSE:DGX
Quest Diagnostics
|
136.34 | -5.51% | 3.66% | 15,146.23 | 2.18% | 6.66% |
|
NYSE:ELAN
Elanco Animal Health
|
13.47 | 47.2% | 65.21% | 6,487.49 | 0% | -5.48% |
|
LSE:DPH
Dechra Pharmaceuticals PLC
|
38.66 | 13.15% | 28.15% | 4,403.6 | 0% | 4.56% |
|
SEHK:1548
Genscript Biotech
|
12.34 | -,290.21% | -45.76% | 24,723.97 | 0% | 0% |
|
NasdaqGS:MYGN
Myriad Genetics
|
19.22 | -,100.22% | -86.54% | 1,770.66 | 0% | 0% |
|
NasdaqGM:FLGT
Fulgent Genetics
|
21.24 | -,119.73% | -,113.48% | 608.48 | 0% | 0% |
|
NasdaqGS:DMRC
Digimarc
|
22.61 | 0% | 0% | 480.88 | 0% | 0% |
|
AIM:MXCT
MaxCyte
|
2.97 | 0% | 0% | 308.33 | 0% | 0% |
|
NasdaqGS:PGEN
Precigen
|
1.40 | 0% | 0% | 328.57 | 0% | 0% |
|
LSE:DLAR
De La Rue
|
0.93 | -34.4% | 11.36% | 151.62 | 0% | 0% |
|
OTCPK:IEHC
IEH
|
7.60 | 0% | 0% | 18.72 | 0% | 6.65% |
|
ASX:DDT
DataDot Technology
|
0.00 | 0% | 0% | 5.45 | 0% | 0% |
